BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9647587)

  • 1. Chronic mucosal changes of the colon in graft-versus-host disease.
    Asplund S; Gramlich TL
    Mod Pathol; 1998 Jun; 11(6):513-5. PubMed ID: 9647587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study.
    Akpek G; Chinratanalab W; Lee LA; Torbenson M; Hallick JP; Anders V; Vogelsang GB
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):46-51. PubMed ID: 12533741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic findings predict the histologic diagnosis in gastrointestinal graft-versus-host disease.
    Cruz-Correa M; Poonawala A; Abraham SC; Wu TT; Zahurak M; Vogelsang G; Kalloo AN; Lee LA
    Endoscopy; 2002 Oct; 34(10):808-13. PubMed ID: 12244503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review.
    Daniels JA; Lederman HM; Maitra A; Montgomery EA
    Am J Surg Pathol; 2007 Dec; 31(12):1800-12. PubMed ID: 18043034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic intestinal graft-versus-host disease: clinical, histological and immunohistochemical analysis of 17 children.
    Patey-Mariaud de Serre N; Reijasse D; Verkarre V; Canioni D; Colomb V; Haddad E; Brousse N
    Bone Marrow Transplant; 2002 Feb; 29(3):223-30. PubMed ID: 11859394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow.
    Heldal D; Brinch L; Evensen SA; Tjønnfjord GE; Aamodt G; Elgjo K; Sviland L
    Bone Marrow Transplant; 2004 Aug; 34(4):345-50. PubMed ID: 15170163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the presence of 6 or fewer crypt apoptotic bodies sufficient for diagnosis of graft versus host disease? A decade of experience at a single institution.
    Lin J; Fan R; Zhao Z; Cummings OW; Chen S
    Am J Surg Pathol; 2013 Apr; 37(4):539-47. PubMed ID: 23211294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the colonoscopic features of GVHD enteritis that developed after hematopoietic stem cell transplantation.
    Harada K; Higaki S; Hashimoto K; Hashimoto S; Oga A; Gondo T; Sakaida I
    Hepatogastroenterology; 2007 Dec; 54(80):2221-7. PubMed ID: 18265637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance of incidental chronic colitis: a study of 17 cases.
    Deshpande V; Hsu M; Kumarasinghe MP; Lauwers GY
    Am J Surg Pathol; 2010 Apr; 34(4):463-9. PubMed ID: 20154590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features in patients with hepatic graft-versus-host disease.
    Chiba T; Yokosuka O; Goto S; Fukai K; Imazeki F; Kohno Y; Nishimura M; Saito Y; Saisho H
    Hepatogastroenterology; 2005; 52(66):1849-53. PubMed ID: 16334791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo diagnosis of acute intestinal graft-versus-host disease by confocal endomicroscopy.
    Bojarski C; Günther U; Rieger K; Heller F; Loddenkemper C; Grünbaum M; Uharek L; Zeitz M; Hoffmann JC
    Endoscopy; 2009 May; 41(5):433-8. PubMed ID: 19418398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
    Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
    Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective endoscopic evaluation for gastrointestinal graft-versus-host disease: determination of the best diagnostic approach.
    Thompson B; Salzman D; Steinhauer J; Lazenby AJ; Wilcox CM
    Bone Marrow Transplant; 2006 Sep; 38(5):371-6. PubMed ID: 16915225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
    Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies.
    Ross WA; Ghosh S; Dekovich AA; Liu S; Ayers GD; Cleary KR; Lee JH; Couriel D
    Am J Gastroenterol; 2008 Apr; 103(4):982-9. PubMed ID: 18028511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathology of graft versus host disease of the liver.
    Quaglia A; Duarte R; Patch D; Ngianga-Bakwin K; Dhillon AP
    Histopathology; 2007 May; 50(6):727-38. PubMed ID: 17493237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of gastrointestinal graft-versus-host disease--is rectal biopsy enough?
    Nydegger A; Catto-Smith AG; Tiedemann K; Hardikar W
    Pediatr Blood Cancer; 2007 May; 48(5):561-6. PubMed ID: 16862539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
    Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.